Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort

28, Jan 2026

2
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Role of Rare Genetic Variants in Multiple Sclerosis Pathogenesis

27, Jan 2026

3
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis
Genetics
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis

26, Jan 2026

4
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk

25, Jan 2026

5
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis
Genetics
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis

23, Jan 2026

Categories:
Genetics
Predicting Glatiramer Acetate Treatment Response in RRMS: A Promising Gene Expression Biomarker Signature
Genetics
Predicting Glatiramer Acetate Treatment Response in RRMS: A Promising Gene Expression Biomarker Signature

25, May 2025

Molecular Code of MS: How RNA Splicing and Inflammation Shape Lesion Stages and Treatment Response
Genetics
Molecular Code of MS: How RNA Splicing and Inflammation Shape Lesion Stages and Treatment Response

27, May 2025

EOMES and TBX21 Expression Reveals Stable, Heritable, and Drug-Sensitive Biomarkers in Multiple Sclerosis
Genetics
EOMES and TBX21 Expression Reveals Stable, Heritable, and Drug-Sensitive Biomarkers in Multiple Sclerosis

27, May 2025

Teaching Computers to Spot Who Will Benefit from Interferon-β in Multiple Sclerosis
Genetics
Teaching Computers to Spot Who Will Benefit from Interferon-β in Multiple Sclerosis

29, May 2025